BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 28951476)

  • 1. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
    de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
    Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
    J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.
    Botterel F; Angebault C; Cabaret O; Stressmann FA; Costa JM; Wallet F; Wallaert B; Bruce K; Delhaes L
    Mycopathologia; 2018 Feb; 183(1):171-183. PubMed ID: 28766039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
    Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
    Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung function and microbiota diversity in cystic fibrosis.
    Cuthbertson L; Walker AW; Oliver AE; Rogers GB; Rivett DW; Hampton TH; Ashare A; Elborn JS; De Soyza A; Carroll MP; Hoffman LR; Lanyon C; Moskowitz SM; O'Toole GA; Parkhill J; Planet PJ; Teneback CC; Tunney MM; Zuckerman JB; Bruce KD; van der Gast CJ
    Microbiome; 2020 Apr; 8(1):45. PubMed ID: 32238195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain-Resolved Dynamics of the Lung Microbiome in Patients with Cystic Fibrosis.
    Dmitrijeva M; Kahlert CR; Feigelman R; Kleiner RL; Nolte O; Albrich WC; Baty F; von Mering C
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
    Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
    PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease.
    Hogan DA; Willger SD; Dolben EL; Hampton TH; Stanton BA; Morrison HG; Sogin ML; Czum J; Ashare A
    PLoS One; 2016; 11(3):e0149998. PubMed ID: 26943329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients.
    Al-Momani H; Perry A; Stewart CJ; Jones R; Krishnan A; Robertson AG; Bourke S; Doe S; Cummings SP; Anderson A; Forrest T; Griffin SM; Brodlie M; Pearson J; Ward C
    Sci Rep; 2016 Jun; 6():26985. PubMed ID: 27245316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic footprint of the airway bacterial community in cystic fibrosis.
    Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
    Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The altered gut microbiota in adults with cystic fibrosis.
    Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
    BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.
    Caverly LJ; Lu J; Carmody LA; Kalikin LM; Shedden K; Opron K; Azar M; Cahalan S; Foster B; VanDevanter DR; Simon RH; LiPuma JJ
    Ann Am Thorac Soc; 2019 Dec; 16(12):1534-1542. PubMed ID: 31415187
    [No Abstract]   [Full Text] [Related]  

  • 14. Data Mining of Lung Microbiota in Cystic Fibrosis Patients.
    Li J; Hao C; Ren L; Xiao Y; Wang J; Qin X
    PLoS One; 2016; 11(10):e0164510. PubMed ID: 27741283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.
    Carmody LA; Caverly LJ; Foster BK; Rogers MAM; Kalikin LM; Simon RH; VanDevanter DR; LiPuma JJ
    PLoS One; 2018; 13(3):e0194060. PubMed ID: 29522532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of airway microbiota in adults from a Brazilian cystic fibrosis center.
    Leite CCF; de Freitas FAD; de Cássia Firmida M; Leão RS; Albano RM; Marques EA
    Braz J Microbiol; 2020 Dec; 51(4):1747-1755. PubMed ID: 32944872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: Differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements.
    Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Abraham WR; Höfle MG
    J Clin Microbiol; 2015 Sep; 53(9):2900-7. PubMed ID: 26135861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease.
    Bacci G; Mengoni A; Fiscarelli E; Segata N; Taccetti G; Dolce D; Paganin P; Morelli P; Tuccio V; De Alessandri A; Lucidi V; Bevivino A
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis.
    Prevaes SM; de Winter-de Groot KM; Janssens HM; de Steenhuijsen Piters WA; Tramper-Stranders GA; Wyllie AL; Hasrat R; Tiddens HA; van Westreenen M; van der Ent CK; Sanders EA; Bogaert D
    Am J Respir Crit Care Med; 2016 Mar; 193(5):504-15. PubMed ID: 26492486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period.
    Stokell JR; Gharaibeh RZ; Hamp TJ; Zapata MJ; Fodor AA; Steck TR
    J Clin Microbiol; 2015 Jan; 53(1):237-47. PubMed ID: 25392361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.